These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11699220)

  • 1. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
    Uckun FM; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon PS; Sather H; Heerema N
    Leuk Lymphoma; 2001 Jun; 42(1-2):41-56. PubMed ID: 11699220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
    Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
    Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission.
    Endo C; Oda M; Nishiuchi R; Seino Y
    Pediatr Int; 2003 Jun; 45(3):275-80. PubMed ID: 12828580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia.
    Loh ML; Silverman LB; Young ML; Neuberg D; Golub TR; Sallan SE; Gilliland DG
    Blood; 1998 Dec; 92(12):4792-7. PubMed ID: 9845546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
    Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P
    Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification.
    Maloney K; McGavran L; Murphy J; Odom L; Stork L; Wei Q; Hunger S
    Leukemia; 1999 Nov; 13(11):1708-12. PubMed ID: 10557042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.
    Krishna Narla R; Navara C; Sarquis M; Uckun FM
    Leuk Lymphoma; 2001 May; 41(5-6):615-23. PubMed ID: 11378579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods.
    Taube T; Eckert C; Körner G; Henze G; Seeger K
    Leuk Res; 2004 Jul; 28(7):699-706. PubMed ID: 15158091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia.
    Drunat S; Olivi M; Brunie G; Grandchamp B; Vilmer E; Bièche I; Cavé H
    Br J Haematol; 2001 Aug; 114(2):281-9. PubMed ID: 11529845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia.
    Park HJ; Lee KE; Um JM; Choe SY; Chi XZ; Lee JA; Shin HY; Ahn HS; Bae SC
    Mol Cells; 2000 Feb; 10(1):90-5. PubMed ID: 10774753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.